Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 1 | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 3 | — | — |
15 children received a dose of PEDVAX HIB at 2 months old, 4 months old, and an extra dose at 6 months old; no additional AE reported.; This spontaneous report was received from a nurse and refers to a 6-month-old patient of unknown gender. The patient's medical history, concurrent conditions, previous drugs reactions or allergies and concomitant therapies were not reported. On an unknown date, at the age of 2 months the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB), then, at the age of 4 months old, the patient was vaccinated with a second dose, and at the age of 6 months, the patient received an extra dose (Extra dose administered) (lot #s, dose descriptions, anatomical locations, routes of administration and expiration dates were not reported) as prophylaxis. No additional adverse event was reported. This is 1 of 15 cases received from the same reporter.